These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28574010)

  • 1. Rare cancers: Challenges & issues.
    Pillai RK; Jayasree K
    Indian J Med Res; 2017 Jan; 145(1):17-27. PubMed ID: 28574010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.
    Ray-Coquard I; Trama A; Seckl MJ; Fotopoulou C; Pautier P; Pignata S; Kristensen G; Mangili G; Falconer H; Massuger L; Sehouli J; Pujade-Lauraine E; Lorusso D; Amant F; Rokkones E; Vergote I; Ledermann JA;
    Eur J Surg Oncol; 2019 Jan; 45(1):67-74. PubMed ID: 29108961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accepting risk in the acceleration of drug development for rare cancers.
    Ashley D; Thomas D; Gore L; Carter R; Zalcberg JR; Otmar R; Savulescu J
    Lancet Oncol; 2015 Apr; 16(4):e190-4. PubMed ID: 25846099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based data and rare cancers: The need for a new methodological approach in research and investigation.
    Mathoulin-Pélissier S; Pritchard-Jones K
    Eur J Surg Oncol; 2019 Jan; 45(1):22-30. PubMed ID: 29526369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial design for rare cancers: why a less conventional route may be required.
    Panageas KS
    Expert Rev Clin Pharmacol; 2015; 8(6):661-3. PubMed ID: 26517109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.
    Bogaerts J; Sydes MR; Keat N; McConnell A; Benson A; Ho A; Roth A; Fortpied C; Eng C; Peckitt C; Coens C; Pettaway C; Arnold D; Hall E; Marshall E; Sclafani F; Hatcher H; Earl H; Ray-Coquard I; Paul J; Blay JY; Whelan J; Panageas K; Wheatley K; Harrington K; Licitra L; Billingham L; Hensley M; McCabe M; Patel PM; Carvajal R; Wilson R; Glynne-Jones R; McWilliams R; Leyvraz S; Rao S; Nicholson S; Filiaci V; Negrouk A; Lacombe D; Dupont E; Pauporté I; Welch JJ; Law K; Trimble T; Seymour M
    Eur J Cancer; 2015 Feb; 51(3):271-81. PubMed ID: 25542058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of rare cancer in Japan: application of the RARECARE definition.
    Tamaki T; Dong Y; Ohno Y; Sobue T; Nishimoto H; Shibata A
    Cancer Epidemiol; 2014 Oct; 38(5):490-5. PubMed ID: 25155209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering-A Cross-Sectional Analysis.
    Stockklausner C; Lampert A; Hoffmann GF; Ries M
    Oncologist; 2016 Apr; 21(4):487-93. PubMed ID: 27022038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the design of small population clinical trials.
    Day S; Jonker AH; Lau LPL; Hilgers RD; Irony I; Larsson K; Roes KC; Stallard N
    Orphanet J Rare Dis; 2018 Nov; 13(1):195. PubMed ID: 30400970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Challenge of Rare Cancers in Current and Advancing Treatment.
    Houlihan NG
    Oncol Nurs Forum; 2015 Sep; 42(5):566-7. PubMed ID: 26302288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare cancers: a sea of opportunity.
    Boyd N; Dancey JE; Gilks CB; Huntsman DG
    Lancet Oncol; 2016 Feb; 17(2):e52-e61. PubMed ID: 26868354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Challenges for clinical research on rare tumors in Europe].
    Blay JY
    Bull Acad Natl Med; 2013 Jan; 197(1):103-21; discussion 121-2. PubMed ID: 24672983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare cancers in Japan: definition, clinical features and future perspectives.
    Kawai A; Higashi T; Shibata T; Yoshida A; Katoh Y; Fujiwara Y; Nishida T
    Jpn J Clin Oncol; 2020 Sep; 50(9):970-975. PubMed ID: 32719865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status and future outlook for patient-derived cancer models from a rare cancer research perspective.
    Kondo T
    Cancer Sci; 2021 Mar; 112(3):953-961. PubMed ID: 32986888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives for improving the evaluation and access of therapies for rare lung diseases in Europe.
    Luisetti M; Balfour-Lynn IM; Johnson SR; Miravitlles M; Strange C; Trapnell BC; van Bronswijk H; Vogelmeier C
    Respir Med; 2012 Jun; 106(6):759-68. PubMed ID: 22414566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New clinical research strategies for rare gynecologic malignancies.
    Ray-Coquard I; Pujade-Lauraine E; Ledermann JA
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):53-7. PubMed ID: 25490380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.